-
公开(公告)号：EP1458247A2
公开(公告)日：2004-09-22
申请号：EP02787279.5
申请日：2002-12-20
发明人： SIMARD, Eric , PILOTE, Dominique , DUPONT, Claude , LAJOIE, Nathalie , PAQUET, Marcel , LEMIEUX, Pierre , GOYETTE, Philippe
CPC分类号： A61K35/74 , A23C9/1307 , A23C9/1315 , A23C13/14 , A23C15/16 , A23J3/00 , A23J3/08 , A23J3/22 , A23L27/60 , A23L33/135 , A23V2002/00 , A23Y2220/47 , A61K8/64 , A61K8/99 , A61K9/0014 , A61K9/1658 , A61K35/20 , A61K35/742 , A61K35/744 , A61K35/745 , A61K35/747 , A61K36/064 , A61K38/00 , A61K47/42 , A61K2800/85 , A61Q1/02 , A61Q19/00 , C12N1/20 , C12N11/02 , C12N15/63 , A23V2200/242 , A23V2250/54252 , A23V2200/124
摘要： The present invention relates to a malleable protein matrice (MPM), which is the reaction product of the agglomeration of proteins after a fermentation process and is exhibiting biological activities and is suitable for the incorporation (or encapsulation) of various hydrophilic or lipophylic substances. The present invention also relates to the process for the preparation of the malleable protein matrice and its usages.
-
公开(公告)号：EP1569616A2
公开(公告)日：2005-09-07
申请号：EP03767330.8
申请日：2003-12-04
IPC分类号： A61K9/107
CPC分类号： A61K9/1075 , A61K9/0014 , A61K9/0019 , A61K9/2009 , A61K31/337 , A61K31/425 , A61K31/715 , A61K47/36
摘要： The present invention relates to a delivery system for delivery of an active molecule to a patient, the delivery system comprising a population of exopolysaccharide micelles, each micelle defining a core for containing the active molecule.
-
3.发明公开METHOD OF REGULATING THE TH17 PATHWAY AND ITS ASSOCIATED METABOLIC IMPACT 有权MPM（ABLE MALLE蛋白质基质）FOR USE IN肥胖，胰岛素抵抗，2型糖尿病，自身免疫性疾病，高血压和高脂血症的治疗
公开(公告)号：EP2205259A1
公开(公告)日：2010-07-14
申请号：EP08800421.3
申请日：2008-10-02
发明人： BEAULIEU, Josée , LAPOINTE, Jean-François , DUPONT, Claude , LEMIEUX, Pierre , SIMARD, Eric , TROTTIER, Eric
CPC分类号： A61K38/018
摘要： It is disclosed a method of immunomodulating an immune response in a subject comprising administering to a subject a malleable protein matrix (MPM), from fermented whey, in an amount effective to modulate the biological activity of Th17 cells, and its associated metabolic pathway, for a preventative or a therapeutic purpose of a variety of health applications in the field of immunity or obesity related diseases.
-
4.发明授权MPM (MALLEABLE PROTEIN MATRIX) FOR USE IN THE TREATMENT OF ARTHRITIS, OBESITY, INSULIN RESISTANCE, TYPE 2 DIABETES, AUTOIMMUNE DISEASE, HYPERTENSION, AND HYPERLIPIDEMIA 有权MPM（ABLE MALLE蛋白质基质）FOR USE IN肥胖，胰岛素抵抗，2型糖尿病，自身免疫性疾病，高血压和高脂血症的治疗
公开(公告)号：EP2205259B1
公开(公告)日：2014-12-10
申请号：EP08800421.3
申请日：2008-10-02
发明人： BEAULIEU, Josée , LAPOINTE, Jean-François , DUPONT, Claude , LEMIEUX, Pierre , SIMARD, Eric , TROTTIER, Eric
CPC分类号： A61K38/018
-
-
-
搜索结果
4 条记录 (耗时 0.011 秒)
